10x Genomics, Inc. (TXG) Gross margin 2017–2025
10x Genomics, Inc. (TXG) gross margin by fiscal year — reported gross profit divided by reported revenue.
69.1%FY2025 · since FY2017: 85.1% → 69.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 69.1% | +1.2 pp |
| FY2024 | 67.9% | +1.7 pp |
| FY2023 | 66.2% | -10.5 pp |
| FY2022 | 76.7% | -8.2 pp |
| FY2021 | 84.9% | +4.5 pp |
| FY2020 | 80.4% | +5.3 pp |
| FY2019 | 75.2% | -5.2 pp |
| FY2018 | 80.4% | -4.7 pp |
| FY2017 | 85.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice